Edmond de Rothschild Holding’s Pacific Biosciences PACB Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-10,675,200	Closed	-$13.7M	–	597
2025 Q3	$13.7M	Sell	10,675,200 -2,691,000	-20%	-$3.64M	0.21%	102
2025 Q2	$16.6M	Sell	13,366,200 -8,488,980	-39%	-$9.8M	0.26%	93
2025 Q1	$25.8M	Buy	21,855,180 +508,700	+2%	+$780K	0.46%	60
2024 Q4	$39.1M	Buy	21,346,480 +1,038,600	+5%	+$2.03M	0.67%	35
2024 Q3	$34.5M	Buy	20,307,880 +3,571,460	+21%	+$5.87M	0.56%	45
2024 Q2	$22.9M	Buy	16,736,420 +6,229,133	+59%	+$12.6M	0.39%	66
2024 Q1	$39.4M	Buy	10,507,287 +9,511,787	+955%	+$55.7M	0.66%	42
2023 Q4	$9.77M	Buy	995,500 +188,600	+23%	+$1.54M	0.17%	131
2023 Q3	$6.74M	Buy	806,900 +379,400	+89%	+$4.34M	0.14%	141
2023 Q2	$5.69M	Buy	+427,500	New	+$5.2M	0.11%	162
2017 Q2	–	Sell	-1,100	Closed	-$6K	–	846
2017 Q1	$6K	Buy	+1,100	New	+$5.38K	﹤0.01%	787
2016 Q4	–	Sell	-5,560	Closed	-$50K	–	869
2016 Q3	$50K	Buy	+5,560	New	+$46.5K	﹤0.01%	665
2015 Q4	–	Sell	-12,000	Closed	-$44K	–	866
2015 Q3	$44K	Sell	12,000 -14,000	-54%	-$68.4K	﹤0.01%	639
2015 Q2	$150K	Buy	+26,000	New	+$150K	﹤0.01%	519